First Trust Nasdaq Pharmaceuticals ETF (FTXH) |
| 34.6015 0.412 (1.2%) 04-14 14:35 |
| Open: | 34.49 |
| High: | 34.655 |
| Low: | 34.49 |
| Volume: | 2,047 |
| Market Cap: | 29(M) |
| PE Ratio: | 22.39 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 40.79 |
| Resistance 1: | 34.92 |
| Pivot price: | 34.01 |
| Support 1: | 33.63 |
| Support 2: | 32.84 |
| 52w High: | 35.611 |
| 52w Low: | 23.83 |
The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks to replicate the holdings and weightings of the Nasdaq US Smart Pharmaceuticals Index so as to generate performance results 95% correlated to that of the Nasdaq US Smart Pharmaceuticals Index.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Sat, 11 Apr 2026
First Trust NASDAQ Pharmaceuticals ETF declares quarterly distribution of $0.0573 - MSN
Sat, 15 Nov 2025
Eli Lilly Supremacy: The Single Stock Steering Pharma ETF Performance - First Trust Nasdaq Pharmaceutical - Benzinga
Thu, 16 Oct 2025
ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook - TradingView — Track All Markets
Thu, 17 Jul 2025
ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook - Yahoo Finance
Mon, 12 May 2025
Pharma ETFs in Focus on Trump's Drug Price Overhaul - Yahoo Finance
Wed, 17 Apr 2024
The 5 Best Pharmaceutical ETFs of 2023 - ETF.com
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
